TY - JOUR
T1 - Effect of single and combined immunostimulants on growth, anti-oxidation activity, non-specific immunity and resistance to Aeromonas hydrophila in Chinese mitten crab (Eriocheir sinensis)
AU - Lu, Jianting
AU - Bu, Xianyong
AU - Xiao, Shusheng
AU - Lin, Zhideng
AU - Wang, Xinyue
AU - Jia, Yongyi
AU - Wang, Xiaodan
AU - Qin, Jian G.
AU - Chen, Liqiao
PY - 2019/10
Y1 - 2019/10
N2 - This study evaluates the effect of dietary supplementation of immunostimulants on the Chinese mitten crab (Eriocheir sinensis) with a single administration of mannan oligosaccharide (MOS), or its combination with either β-glucan or with inulin for 8 weeks. Four diets included an untreated control diet (C), MOS alone (3 g kg−1, M), MOS with β-glucan (3 g kg −1 MOS + 1.5 g kg −1 β-glucan, MB), and MOS with inulin (3 g kg −1 MOS + 10 g kg −1 inulin, MI). The weight gain and specific growth rate of the crabs fed M, MB, and MI diets were improved by lowing feed conversion ratio. The growth and feed utilization of the crabs fed the MB diet were improved compared with the other three groups. The crabs fed the M, MB and MI diets showed a higher intestinal trypsin activity than that in the M and control groups. The highest trypsin activity in the hepatopancreas was observed in the MB group. Crabs fed M, MB and MI diets increased antioxidant system-related enzyme activities, but reduced malondialdehyde. The highest activities of alkaline phosphatase, acid phosphatase, lysozyme and phenol oxidase in the gut and the respiratory burst of the crabs were found in the MB group. The MB diet promoted the mRNA expression of E. sinensis immune genes (ES-PT, ES-Relish, ES-LITAF, p38MAPK and Crustin) compared with the control. After 3 days of infection with Aeromonas hydrophila, the highest survival of crabs was also found in the MB group. This study indicates that the combination of MOS with β-glucan or with inulin can improve growth, antioxidant capacity, non-specific immunity and disease resistance in E. sinensis.
AB - This study evaluates the effect of dietary supplementation of immunostimulants on the Chinese mitten crab (Eriocheir sinensis) with a single administration of mannan oligosaccharide (MOS), or its combination with either β-glucan or with inulin for 8 weeks. Four diets included an untreated control diet (C), MOS alone (3 g kg−1, M), MOS with β-glucan (3 g kg −1 MOS + 1.5 g kg −1 β-glucan, MB), and MOS with inulin (3 g kg −1 MOS + 10 g kg −1 inulin, MI). The weight gain and specific growth rate of the crabs fed M, MB, and MI diets were improved by lowing feed conversion ratio. The growth and feed utilization of the crabs fed the MB diet were improved compared with the other three groups. The crabs fed the M, MB and MI diets showed a higher intestinal trypsin activity than that in the M and control groups. The highest trypsin activity in the hepatopancreas was observed in the MB group. Crabs fed M, MB and MI diets increased antioxidant system-related enzyme activities, but reduced malondialdehyde. The highest activities of alkaline phosphatase, acid phosphatase, lysozyme and phenol oxidase in the gut and the respiratory burst of the crabs were found in the MB group. The MB diet promoted the mRNA expression of E. sinensis immune genes (ES-PT, ES-Relish, ES-LITAF, p38MAPK and Crustin) compared with the control. After 3 days of infection with Aeromonas hydrophila, the highest survival of crabs was also found in the MB group. This study indicates that the combination of MOS with β-glucan or with inulin can improve growth, antioxidant capacity, non-specific immunity and disease resistance in E. sinensis.
KW - Antioxidant capacity
KW - Chinese mitten crab
KW - Disease resistance
KW - Inulin
KW - Mannan oligosaccharide
KW - Non-specific immunity
KW - β-glucan
UR - http://www.scopus.com/inward/record.url?scp=85070759828&partnerID=8YFLogxK
U2 - 10.1016/j.fsi.2019.08.027
DO - 10.1016/j.fsi.2019.08.027
M3 - Article
C2 - 31415901
AN - SCOPUS:85070759828
SN - 1050-4648
VL - 93
SP - 732
EP - 742
JO - Fish and Shellfish Immunology
JF - Fish and Shellfish Immunology
ER -